.jpg?format=webp&width=780)
This study aimed to reveal the relationship between obesity and asprosin (fibrillin‐1) in patients undergoing bariatric surgery and to investigate the role of asprosin in obesity etiopathogenesis. A significant intergroup difference in terms of mean asprosin levels in adipose tissue was noted. Serum asprosin levels decreased significantly six months after bariatric surgery. Adipose tissue of patients with obesity showed high asprosin levels and immunoreactivity. In conclusion, asprosin levels in adipose tissue were considered a potential independent risk factor in obesity etiopathogenesis.
Like
Save
Share